$40 – $55


Event Information

Share this event

Date and Time




Seaport West

155 Seaport Boulevard

Boston, Massachusetts 02210

View Map

Friends Who Are Going
Event description



NOVEMBER 6, 2017, 7:30AM TO 10:00AM


Seaport West
155 Seaport Boulevard
Boston, MA 02210

For Driving and Parking Information, Click Here

This month's meeting is in concurrence with Boston Irish Business Association (BIBA)

Boston Irish Business Association

Meeting sponsored by Paul Toomey, Wells Fargo Advisors

Wells Fargo Advisors

Program Description:

This event is to draw attention to the highly synergistic regions of Massachusetts and Ireland as it relates to BioPharma, Medical Device/MedTech product development and manufacturing. We will bring a variety of perspectives from both sides to understand the value proposition presented for inward and outward investment to/from Ireland.

Keynote Speaker:

Ger Brophy – General Manager, Cell Therapy - GE Healthcare Life Sciences

Ger leads the Cell Therapy division of Life Sciences within GE Healthcare developing & commercializing products for autologous & allogenic cell therapy.


Laura Hamilton, Executive VP, US Operations, RxCelerate Inc.; President, BIBA

Laura was born in Cork City, Ireland and resides in Boston; having strong business connections within life sciences in Massachusetts and Ireland.


Dave Shanahan, President of Partnerships, BeaconHealth

Dave is the President of Partnerships at HealthBeacon, a medical adherence technology company developing smart tools for managing medication.

Aiden O'Dwyer - President, US Operations, DPS Engineering

Aiden has full US operational responsibility for DPS' Architectural & Engineering design, and Construction Management.

Join this future focused, visionary, and engaging blue ribbon panel of experts. Ask questions. Contribute your insights during the audience interactive segment.

Topics for Discussion:

  • The many benefits of expanding life science businesses into Ireland: Highly talented workforce, favorable tax rate, English speaking country with access to the Euro Zone, a great place to live, work, and invest,
  • Ireland’s strengths: Medical Device/MedTech product development and BioManufacturing,
  • Synergies between Ireland and Massachusetts, are encouraging indigenous Irish businesses to enter US market, by way of Massachusetts,
  • Building on the past successes, where do the future opportunities lie?

Who should attend:

CEOs, CMOs, CTOs, CFOs, technologists, investors, and business experts seeking a better understanding of business opportunities in Ireland and Irish businesses who have located to Massachusetts.

Speaker Bios:

Ger Brophy – General Manager, GE Healthcare Life Sciences

Ger Brophy is Head of Cell Therapy for GE Healthcare Life Science, where he is responsible for the development and commercialization of products to enable manufacture of Cell Therapies. He has over 20 years’ experience in the global life sciences and biotechnology industry.

Previously Ger was Chief Technology Officer. In this role, he was responsible for the overarching technology and development strategy of the business – ranging from Research Tools in academia, through Bioprocessing tools in Pharma Drug Development to Imaging and In Vitro Tools for clinical diagnosis.

Before that, Ger was Head of New Product Development at GE Healthcare Medical Diagnostics; encompassing the development of in vivo and in vitro diagnostic technologies, with oversight of discovery (research) and clinical development; regulatory and medical affairs; project and portfolio management; product acquisition and licensing; R&D efficiency projects and collaborations across GE.

He has also led Strategic Planning & Licensing within the Medical Diagnostics business. He was centrally involved in the expansion of the business into the Personalized Medicine space through inorganic and organic investments in in vitro diagnostics and pathology. Before joining the Medical Diagnostics business, Ger ran the Life Sciences Advanced Systems business in Sweden; focusing on the commercialization of improved tools for drug discovery.

Ger joined GE Healthcare through the acquisition of Amersham in 2004. He has had international assignments in the UK, Sweden and in Chicago & New Jersey relocating to the US in 2017. Ger holds a Ph.D. in Molecular Biology.

Dave Shanahan, President of Partnerships, BeaconHealth

Dave Shanahan is an Irish science and business graduate with a long career in pharmaceuticals where he held senior executive commercial positions with Zeneca, Pfizer, Abbott and AbbVie in Ireland, UK and USA. His interests in healthcare and life sciences led him to become founding CEO of Charter Medical Ltd - an innovative specialist healthcare provider in the Irish community. He led the Irish Government's global inward investment team in life sciences in IDA for three years attracting foreign direct investment to Ireland in pharmaceuticals. medical technologies and healthcare services.

Since returning to Ireland in 2014, he set up Adagio Ventures commercialisation partners to work with industry and subsequently joined the founding team of HealthBeacon Ltd as President Partnerships. In this capacity he works to develop international collaborations with biopharmaceutical companies using HealthBeacon’s technology platforms to improve patient support at home. HealthBeacon is an award-winning platform using smart tools to assist patients manage their medications.

Dave is also a board member of Enterprise Ireland, the national agency responsible for SME development and is the inaugural chair of Health Innovation Hub Ireland which seeks to support health-industry collaboration. He is also one of six industry partners advising government on industrial strategy under the action plan for jobs framework. He is married to Eilis a clinical nurse specialist in diabetes with three adult children.

Aidan O'Dwyer - President, US Operations & Board of Directors, DPS Engineering

Aidan O’Dwyer, President of DPS—a 40+ year old global Irish-based architectural, engineering and construction firm serving the biosciences, semiconductor and speciality chemical industry, has over 22 years of industry experience. He was appointed as president in January 2017 to provide strategic leadership to guide the firm’s expansion in the U.S. after having served as the Senior Vice President of Operations in the Framingham, Mass. office, from 2011-2017, when the firm opened its first U.S. life sciences division through the acquisition of BioMetics. Aidan played a pivotal role in expanding the operation’s portfolio and growing the team from eleven employees to currently a staff of over 130.

Prior to his roles as president and SVP, O’Dwyer held senior management positions with DPS in its Ireland office starting as a construction manager in 2005, and later as a senior project manager where he was responsible for the delivery of capital projects ranging in value from $10 - $100M for clients such as Pfizer, Merck, GSK, Eli Lilly and Janssen, across various geographic locations, which included Ireland, the United Kingdom, Holland and Belgium. Before joining DPS and moving to the U.S., Aidan held senior project management positions with a number of global blue-chip pharmaceutical firms, where he played key roles in the delivery of capital programs ranging from $150 - $350M.

Aidan earned his Bachelor of Science in Applied Physics with Honors from the Cork Institute of Technology, Ireland and is a member of International Society for Pharmaceutical Engineering (ISPE) and MassBio. He lives in Newton, Mass. with his wife Aoife and their three children.

Laura Hamilton, Executive Vice President, US Operations - RxCelerate Inc. & President - BIBA (Boston Irish Business Association)

Originally from Cork City, Ireland and now residing in Boston, Laura is the current president of the Boston Irish Business Association (BIBA). Laura is the Executive Vice President, US Operations at RxCelerate, an outsourced drug development company. In her role, Laura is responsible for leading all aspects of the company’s expansion into the US, as well as overseeing sales, marketing and business development. Prior to this role, Laura was the Director of Business Development at MassBio (Massachusetts Biotechnology Council), onboarding over 650 new companies in 4 years. In 2017, she became a mentor at MassChallenge within their Bridge to MassChallenge program, advising foreign companies on aspects of market entry, market intelligence as well as sales, marketing and business development strategy. Laura has been a BIBA Board Member for several years and was awarded the Boston Irish Business Young Leader Award in 2015. Prior to her work in the biopharma industry, Laura worked for a financial services company, First Marblehead Corporation in Boston.

Laura is a proud member of the Irish Network Boston Board of Directors and is affiliated with many worthwhile organizations: Quincy Chamber of Commerce Young Professionals, the Edward M. Kennedy Institute for the United States Senate - 1787 Society, and the American Heart Association. Laura is a three-time graduate of Northeastern University, holding a BSBA in Finance, a Master’s Degree in Innovation and a Master’s Degree in Business Administration (MBA). Laura is passionate about business, disruptive technology, economic development, international trade and investment, and innovation. She takes great pride in facilitating introductions and connections across her vast, global network.


Share with friends

Date and Time



Seaport West

155 Seaport Boulevard

Boston, Massachusetts 02210

View Map

Save This Event

Event Saved